The Warburg Effect: Is it Always an Enemy?
Frontiers in Bioscience-Landmark · 27.11.2024 · 29 (12)
DOI: 10.31083/j.fbl2912402 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 27.11.2024. Verfasst von Christos Papaneophytou. Beteiligte Einrichtung: Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus. Hauptthemen laut MEDLINE: Warburg Effect, Oncologic, Neoplasms, Glycolysis. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The Warburg effect, also known as ‘aerobic’ glycolysis, describes the preference of cancer cells to favor glycolysis over oxidative phosphorylation for energy (adenosine triphosphate-ATP) production, despite having high amounts of oxygen and fully active mitochondria, a phenomenon first identified by Otto Warburg. This metabolic pathway is traditionally viewed as a hallmark of cancer, supporting rapid growth and proliferation by supplying energy and biosynthetic precursors. However, emerging research indicates that the Warburg effect is not just a strategy for cancer cells to proliferate at higher rates compared to normal cells; thus, it should not be considered an ‘enemy’ since it also plays complex roles in normal cellular functions and/or under stress conditions, prompting a reconsideration of its purely detrimental characterization. Moreover, this review highlights that distinguishing glycolysis as ‘aerobic’ and ‘anaerobic’ should not exist, as lactate is likely the final product of glycolysis, regardless of the presence of oxygen. Finally, this review explores the nuanced contributions of the Warburg effect beyond oncology, including its regulatory roles in various cellular environments and the potential effects on systemic physiological processes. By expanding our understanding of these mechanisms, we can uncover novel therapeutic strategies that target metabolic reprogramming, offering new avenues for treating cancer and other diseases characterized by metabolic dysregulation. This comprehensive reevaluation not only challenges traditional views but also enhances our understanding of cellular metabolism’s adaptability and its implications in health and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.
Zitieren
APA
Papaneophytou, C. (2024). The Warburg Effect: Is it Always an Enemy?. Frontiers in Bioscience-Landmark, 29(12). https://doi.org/10.31083/j.fbl2912402
Vancouver
Papaneophytou C. The Warburg Effect: Is it Always an Enemy?. Frontiers in Bioscience-Landmark. 2024;29(12). doi:10.31083/j.fbl2912402
BibTeX
@article{Papaneophytou2024,
author = {Papaneophytou, Christos},
title = {The Warburg Effect: Is it Always an Enemy?},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
volume = {29},
number = {12},
doi = {10.31083/j.fbl2912402}
}
EUVIMED